While interim results for Sigma Healthcare met expectations, brokers see margin upside from improved operating leverage
Michael Gable of Fairmont Equities notes the pullback for the S&P500 has it sitting on a trendline. It could break either way
The circularity theme kicked off in earnest for the August 2023 reporting season highlighted by packaging companies, biodiversity themes and plenty to say about AI
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is Silk Logistics
The Chartist assesses the technicals for ANZ Bank, as emblematic of why Australian banks should be avoided
Argenica Therapeutics is aiming for a substantial slice of the stroke market, expected to be worth some US$180bn a year by 2030
A glance through the latest expert views and predictions about commodities. Oil prices set to reverse; EV demand to drive lithium rebound; demand for uranium to exceed supply
ASX-listed ESG targets, board expectations of rising decarbonisation capex, the top 10 sustainability topics, AI opportunities, plus lots more!
